90 Biggest Movers From Yesterday
Gainers Hemisphere Media Group, Inc (NASDAQ: HMTV ) shares climbed 78.8% to close at $6.74 on Monday after the company announced it entered into a definitive agreement to be acquired for $7.00 per share in cash by a subsidiary of Gato Investments, a portfolio investment of Searchlight Capital Partners. Blue Water Vaccines, Inc. (NASDAQ: BWV ) gained 44.2% to close at $5.42 on heavy volume. Points.com Inc. (NASDAQ: PCOM ) rose 43.3% to close at $24.46. Plusgrade announced plans to acquire Points for $25 per share in cash. ServiceSource International, Inc. (NASDAQ: SREV ) gained 41.7% to settle at $1.4450 after the company announced it will be acquired by Concentrix Corporation in an all-cash merger. LogicBio Therapeutics, Inc. (NASDAQ: LOGC ) gained 34.4% to close at $0.6673 after the company announced the FDA lifted the clinical hold on its LB-001 Investigational New Drug Application, allowing patient enrollment to resume in the Phase 1|2 SUNRISE trial for pediatric patients with methylmalonic acidemia.
90 Biggest Movers From Yesterday
Gainers Hemisphere Media Group, Inc (NASDAQ: HMTV ) shares climbed 78.8% to close at $6.74 on Monday after the company announced it entered into a definitive agreement to be acquired for $7.00 per share in cash by a subsidiary of Gato Investments, a portfolio investment of Searchlight Capital Partners. Blue Water Vaccines, Inc. (NASDAQ: BWV ) gained 44.2% to close at $5.42 on heavy volume. Points.com Inc. (NASDAQ: PCOM ) rose 43.3% to close at $24.46. Plusgrade announced plans to acquire Points for $25 per share in cash. ServiceSource International, Inc. (NASDAQ: SREV ) gained 41.7% to settle at $1.4450 after the company announced it will be acquired by Concentrix Corporation in an all-cash merger. LogicBio Therapeutics, Inc. (NASDAQ: LOGC ) gained 34.4% to close at $0.6673 after the company announced the FDA lifted the clinical hold on its LB-001 Investigational New Drug Application, allowing patient enrollment to resume in the Phase 1|2 SUNRISE trial for pediatric patients with methylmalonic acidemia.